NCT06235918 2024-02-01Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell CarcinomaTongji HospitalPhase 2 Unknown30 enrolled
NCT04826679 2021-04-01Neoadjuvant Camrelizumab in Combination With Cisplatin and Nab-paclitaxel in Resectable HNSCCSun Yat-sen UniversityPhase 2 Unknown53 enrolled